Author:
Archer Gordon L.,Auger Pierre,Doern Gary V.,Ferraro Mary Jane,Fuchs Peter C.,Jorgensen James H.,Low Donald E.,Murray Patrick R.,Reller L.Barth,Stratton Charles W.,Wennersten Christine B.,Moellering Robert C.
Subject
Infectious Diseases,Microbiology (medical),General Medicine
Reference8 articles.
1. In vitro antistaphylococcal activity and testing of RP 59500, a new streptogramin, by two methods;Aldridge;Antimicrob Agents Chemother,1992
2. Antimicrobial activity against Staphylococcus aureus of semisynthetic injectable streptogramins: RP 59500 and related compounds;Barriere;J Antimicrob Chemother,1992
3. In-vitro and in-vivo synergic activity and fractional inhibitory concentration (FIC) of the components of a semisynthetic streptogramin, RP 59500;Bouanchaud;J Antimicrob Chemother,1992
4. A phase I, double-blind, placebo-controlled study of the tolerance and pharmacokinetic behaviour of RP 59500;Etienne;J Antimicrob Chemother,1992
5. In vitro activity of RP 59500, a semisynthetic injectable pristinamycin, against staphylococci, streptococci and enterococci;Fass;Antimicrob Agents Chemother,1991
Cited by
33 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Streptogramin;Antimicrobial Drug Resistance;2009
2. Daptomycin;Pharmacotherapy;2004-01
3. Macrólidos, cetólidos y estreptograminas;Enfermedades Infecciosas y Microbiología Clínica;2003-04
4. Macrólidos, cetólidos y estreptograminas;Enfermedades Infecciosas y Microbiología Clínica;2003-01
5. Vancomycin Resistance in Staphylococci;Clinical Microbiology Reviews;2002-07